Allan Reine
CEO & DirectorDr. Allan Reine, M.D., had been Chief Financial Officer of Prime Medicine, Inc. since January 17, 2024 until May 2025 and its Chief Executive Officer and Director since May 19, 2025. Dr. Reine is a seasoned executive with experience in the biotechnology industry. He serves as Chairman at ONK Therapeutics Limited since 2023. He has been Independent Non-Executive Director at ONK Therapeutics Limited since March 2022. Prior to joining Prime Medicine in 2024, he served as Chief Financial Officer at Foghorn Therapeutics Inc. since September, 2019 until January 16, 2024. Dr. Reine was an Advisor of Pieris Pharmaceuticals Inc. since September 2019 until December 2019. Prior to joining Foghorn, Dr. Reine had been Senior Vice President and Chief Financial Officer of Pieris Pharmaceuticals, Inc. since August 09, 2017 until September 2019 and served as its Treasurer. Dr. Reine joined Pieris Pharmaceuticals, Inc. in August 2017. Dr. Reine served as Equity Analyst at CIBC World Markets Corp., American Research Division and CIBC World Markets Inc., Research Division. Prior to joining Pieris, from August 2012 to August 2017, he was a Portfolio Manager at Lombard Odier Asset Management, where he ran a healthcare portfolio focused on biotechnology and pharmaceutical companies. Before joining Lombard Odier, he served as a Healthcare Portfolio Manager at various funds, from 2003 to August 2012 including Citi Principal Strategies, SAC Capital, Trivium Capital and Alexandra Investment Management. Previously, Dr. Reine spent fifteen years as a healthcare investor managing various healthcare portfolios primarily focused on biotechnology and pharmaceutical companies. In addition, Dr. Reine started his career in biotechnology investment banking and sell-side research. He began his career in 2001 at CIBC World Markets where he worked in both biotechnology investment banking and biotechnology equity research. Dr. Reine holds M.D. from the University of Toronto and Bachelor of Science in Statistical Sciences from the University of Western Ontario.
Positions
- Company NamePrime Medicine, Inc.Stock CodePRMEPositionCEO & Director
